Serologic response to oncogenic human papillomavirus types in male and female university students in Busan, South Korea

被引:105
作者
Clifford, Gary M.
Shin, Hai-Rim
Oh, Jin-Kyoung
Waterboer, Tim
Ju, Young-Hee
Vaccarella, Salvatore
Quint, Wim
Pawlita, Michael
Franceschi, Silvia
机构
[1] IARC, Lyon 69372, France
[2] Natl Canc Ctr, Res Inst Natl Canc Control & Evaluat, Goyang, South Korea
[3] German Canc Res Ctr, Res Program Infect & Canc, DKFZ, D-6900 Heidelberg, Germany
[4] DDL Diagnost Lab, Voorburg, Netherlands
关键词
D O I
10.1158/1055-9965.EPI-07-0349
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In the absence of genital samples, human papillomavirus (HPV) serology may be useful to assess HPV infection in young men and women. HPV seroprevalence and determinants of seropositivity were assessed in 817 female and 518 male university students in Busan, South Korea, of whom 74% and 44%, respectively, reported never having had penetrative sexual intercourse. Type-specific HPV DNA status, assessed by a short PCR fragment primer set, was available from genital samples. Seropositivity to L1 proteins of HPV types 16, 18, 31, 33, 45, 52, and 58 were assessed using multiplex HPV serology. Among women, HPV seroprevalence was significantly higher among sexually active (26.1%) than nonsexually active students [11.1%, odds ratio (OR) = 2.9; 95% confidence interval (95% CI), 1.8-4.7], although the association was weaker than that for HPV DNA prevalence (OR, 14; 95% CI, 4.7-42). Furthermore, HPV seroprevalence was higher among HPV DNA-positive (24%) than HPV DNA-negative women (13%), and there was a positive correlation of type-specific seroprevalence with the presence of HPV DNA of the same type. In contrast, HPV seropositivity among men was not associated with sexual behavior or the presence of HPV DNA. Seroprevalence correlates with genital HPV exposure in young women, but its meaning in young men is unclear.
引用
收藏
页码:1874 / 1879
页数:6
相关论文
共 44 条
[31]  
Strickler H. D., 1994, Viral Immunology, V7, P169, DOI 10.1089/vim.1994.7.169
[32]  
Strickler HD, 1999, INT J CANCER, V80, P339, DOI 10.1002/(SICI)1097-0215(19990129)80:3&lt
[33]  
339::AID-IJC1&gt
[34]  
3.0.CO
[35]  
2-F
[36]   Polymer-based enzyme-linked immunosorbent assay using human papillomavirus type 16 (HPV16) virus-like particles detects HPV16 clade-specific serologic responses [J].
Studentsov, YY ;
Ho, GYF ;
Marks, MA ;
Bierman, R ;
Burk, RD .
JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (07) :2827-2834
[37]   Population-based human papillomavirus prevalence in Lampang and Songkla, Thailand [J].
Sukvirach, S ;
Smith, JS ;
Tunsakul, S ;
Muñoz, N ;
Kesararat, V ;
Opasatian, O ;
Chichareon, S ;
Kaenploy, V ;
Ashley, R ;
Meijer, CJLM ;
Snijders, PJF ;
Coursaget, P ;
Franceschi, S ;
Herrero, R .
JOURNAL OF INFECTIOUS DISEASES, 2003, 187 (08) :1246-1256
[38]   Seroreactivity to human papillomavirus type 16 virus-like particles is lower in high-risk men than in high-risk women [J].
Svare, EI ;
Kjaer, SK ;
Nonnenmacher, B ;
Worm, AM ;
Moi, H ;
Christensen, RB ;
vandenBrule, AJC ;
Walboomers, JMM ;
Meijer, CJLM ;
Hubbert, NL ;
Lowy, DR ;
Schiller, JT .
JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (04) :876-883
[39]   Seroepidemiology of infection with human papillomavirus 16, in men and women attending sexually transmitted disease clinics in the United States [J].
Thompson, DL ;
Douglas, JM ;
Foster, M ;
Hagensee, ME ;
DiGuiseppi, C ;
Barón, AE ;
Cameron, JE ;
Spencer, TC ;
Zenilman, J ;
Malotte, CK ;
Bolan, G ;
Kamb, ML ;
Peterman, TA .
JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (09) :1563-1574
[40]   Prevalence of antibodies to human papillomavirus (HPV) type 16 virus-like particles in relation to cervical HPV infection among college women [J].
Viscidi, RP ;
Kotloff, KL ;
Clayman, B ;
Russ, K ;
Shapiro, S ;
Shah, KV .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1997, 4 (02) :122-126